Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles

Open Access

Original Article

J App Pharm Sci. 2016; 6(11): 114-119

An Alarming Increase of Fungal Infections in Intensive Care Unit: Challenges in the Diagnosis and Treatment

Richa Gupta, Abida Malik, Meher Rizvi, Moied Ahmed.

Introduction: Fungal infections have risen exponentially and are a cause of significant morbidity and mortality in Intensive Care Unit.The study was done to assess the prevalence of fungal pathogens in ICU patients,their antifungal susceptibility profile and biofilm production.It also aimed at evaluating risk factors and outcome in patients infected with fungal pathogens.
Material and Methods:Samples were collected aseptically from 210 ICU patients from February 2012 to November 2014.They were cultured and identified by standard microbiological techniques.Antifungal susceptibility was performed according to CLSI guidelines.
Results:From 210 ICU patients,52(24.7%) were fungal pathogens.Majority of the fungal pathogens were Candida species 42(82.3%) followed by Aspergillus fumigatus 10(19.2%).Prevalence of Candida species was highest among urinary tract infections 20(39.2%) while that of Aspergillus fumigatus among lower respiratory tract infections 9(17.6%).34.3% of C.albicans and 25% C. dubliniensis were resistant to fluconazole.40% of Aspergillus fumigatus were resistant to fluconazole and ketoconazole.21.8% of C.albicans were resistant to nystatin.C. albicans 19(59.3%) followed by A. fumigatus 6(60%) were the most common biofilm producing fungal isolates.High degree of antibiotic resistance was exhibited by the biofilm film positive isolates compared with biofilm negative isolates.Patients with fungal infection had higher mortality rate(44.3%) as compared to 40% in patients with bacterial infection.
Conclusion:Fungal infections are associated with a high mortality rate.This study confirms the importance of the epidemiological surveillance on fungal infections in the ICU setting for documenting species distribution and antifungal susceptibility patterns to guide therapeutic choices.

Key words: Keywords: Fungal infections, ICU, risk factors, mortality

Similar Articles

Environmental stocks, CEO health risk and COVID-19.
Fernández-Méndez C, Pathan S
Research in international business and finance. 2022; 59(): 101509

Contributing factors common to COVID‑19 and gastrointestinal cancer.
Kostoff RN, Briggs MB, Kanduc D, Shores DR, Kovatsi L, Drakoulis N, Porter AL, Tsatsakis A, Spandidos DA
Oncology reports. 2022; 47(1):

Geographic distribution and time trend of human exposure of Di(2-ethylhexyl) phthalate among different age groups based on global biomonitoring data.
Qu J, Xia W, Qian X, Wu Y, Li J, Wen S, Xu S
Chemosphere. 2022; 287(Pt 2): 132115

What Can Genetic Relatedness Tell Us About Risk Factors for Tuberculosis Transmission?
Leavitt SV, Horsburgh CR, Lee RS, Tibbs AM, White LF, Jenkins HE
Epidemiology (Cambridge, Mass.). 2022; 33(1): 55-64

Vitamin D Supplement Use and Risk of Breast Cancer by Race-Ethnicity.
O'Brien KM, Keil AP, Harmon QE, Jackson CL, White AJ, Díaz-Santana MV, Taylor JA, Sandler DP
Epidemiology (Cambridge, Mass.). 2022; 33(1): 37-47

Full-text options

Latest Statistics about COVID-19
• pubstat.org

Add your Article(s) to Indexes
• citeindex.org

Covid-19 Trends and Statistics
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright ScopeMed Information Services.

ScopeMed Web Sites